Postoperative Confusion Clinical Trial
Official title:
Magnesium Sulphate vs Dexmedetomidine in Prevention of Emergence Agitation in Adults After Nasal Surgeries.
Emergence agitation is a postanesthetic phenomenon that develops in the early phase of general anesthesia recovery, and is characterized by agitation, confusion, disorientation, and possible violent behavior. Though agitation is observed more frequently in pediatric patients, the incidence in adults has been reported at 4.7% or 21.3%. Emergence agitation can lead to serious consequences such as self-extubation, removal of catheters, hemorrhage, and even severe injuries from falling out of the bed. Furthermore, it may increase the demand on human resources and cause medical staff injuries.
Postoperative agitation (POA) although short-lived is potentially harmful to the patient and
the recovery staff. In the postoperative care unit, an agitated patient requires more nurses
to control his abnormal movement and apply restrains that could result in bruises of his
extremities. In the postoperative care unit, we noticed that agitated patients remove venous
and arterial catheters, nasal packs, oxygen masks and endotracheal tubes leading to bleeding
and hypoxia.
Post-operative agitation is a well-documented phenomenon in children recovering from
sevoflurane anesthesia. However, in adults, few reports have highlighted the occurrence of
this phenomenon. The exact trigger for this complication remains to be determined, however,
many factors play a crucial role in revealing POA. While an alert, calm patient is the ideal
recovery outcome, the occurrence of excitation, excessive motor movements and unexplained
sounds is not an uncommon scenario following nasal surgery in adults. Several factors have
been incriminated to provoke agitations in adults; pain, hypoxia, type of operation, too
rapid emergence from anesthesia, sedatives like benzodiazepines.
Post-operative agitation following nasal surgery The incidence of postoperative agitation
following nasal surgery is relatively high. The exact mechanism is Unknown. However, some
studies reported that the occurrence of POA could be as high as 55.4% and the presence of
nasal pack is likely to be the main trigger of agitation. Other experiments reported an
incidence of 68% following nasal surgery. We highlighted several factors that may increase
the prevalence of POA; Male gender, young age, smoking, postoperative pain and premedication
with atropine and Phenergan. Yu et al., 2005 reported a 55% incidence of POA after nasal
surgery. They demonstrated that Doxapram administration, pain, and presence of a tracheal
tube and or a urinary catheter appear to be the most important causes of postoperative
agitation. Similarly, pain, urinary catheters, and tracheal tubes were also reported by Kim
et al., 2004as risk factors for POA following nasal surgery. The presence of nasal pack as a
trigger to POA remains debatable.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02275182 -
Impact of Dexmedetomidine on the Post-Operative Cognition Dysfunction(POCD) in Geriatric Patients
|
Phase 4 | |
Not yet recruiting |
NCT05796830 -
Determination of the Effect of Puzzle Use in Elderly Patients
|
N/A | |
Completed |
NCT02177981 -
Impact of Remote Ischemic Preconditioning Preceding Coronary Artery Bypass Grafting on Inducing nEuroprotection
|
N/A | |
Not yet recruiting |
NCT02134093 -
Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients
|
Phase 4 | |
Completed |
NCT02631135 -
Cognitive Functions After TIVA With Dexmedetomidine
|
Phase 4 | |
Not yet recruiting |
NCT06177847 -
Efficacy of BIS Monitoring in Deep Hypnotic State
|
N/A | |
Completed |
NCT01862302 -
Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium
|
Phase 3 | |
Completed |
NCT01627873 -
Effect of Remifentanil on Postoperative Cognition Function in Patients Undergoing Major Abdominal Surgery
|
Phase 4 | |
Not yet recruiting |
NCT01317407 -
Automated Visual Monitoring for Improving Patient Safety (VIPSafe)
|
N/A | |
Not yet recruiting |
NCT05785689 -
Autonomous Nervous System Regulated Paediatric Anaesthesia With Dexmedetomidine or Placebo
|
Phase 4 |